Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
68
UCTT Quote, Financials, Valuation and Earnings
Last price:
$25.97
Seasonality move
:
-0.39%
Day range:
$23.98 - $25.40
52-week range:
$16.66 - $54.40
Dividend yield:
0%
P/E ratio:
40.79x
P/S ratio:
0.53x
P/B ratio:
1.31x
Volume:
453.6K
Avg. volume:
560.5K
1-year change:
-54.98%
Market cap:
$1.1B
Revenue:
$2.1B
EPS (TTM):
$0.62
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.4B | $2.1B | $2.4B | $1.7B | $2.1B | |
| Revenue Growth (YoY) | 31.18% | 50.27% | 12.98% | -26.95% | 20.93% | |
| Cost of Revenues | $1.1B | $1.7B | $1.9B | $1.5B | $1.7B | |
| Gross Profit | $291.8M | $430M | $465M | $277.3M | $356.3M | |
| Gross Profit Margin | 20.86% | 20.46% | 19.59% | 15.99% | 16.99% | |
| R&D Expenses | $14.8M | $24.5M | $28.5M | $28.3M | $28.3M | |
| Selling, General & Admin | $155.6M | $219.8M | $238.7M | $213.8M | $236.8M | |
| Other Inc / (Exp) | -$5.7M | -$7.6M | -$76.5M | -$1.8M | $17.7M | |
| Operating Expenses | $170.4M | $244.3M | $267.2M | $242.1M | $265.1M | |
| Operating Income | $121.4M | $185.7M | $197.8M | $35.2M | $91.2M | |
| Net Interest Expenses | $16M | $23.8M | $33M | $44.7M | $41.7M | |
| EBT. Incl. Unusual Items | $99.7M | $154.3M | $88.3M | -$11.3M | $67.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $19.3M | $27.9M | $37.9M | $10.9M | $32.7M | |
| Net Income to Company | $80.4M | $126.4M | $50.4M | -$22.2M | $34.5M | |
| Minority Interest in Earnings | -$2.8M | -$6.9M | -$10M | -$8.9M | -$10.8M | |
| Net Income to Common Excl Extra Items | $77.6M | $119.5M | $40.4M | -$31.1M | $23.7M | |
| Basic EPS (Cont. Ops) | $1.93 | $2.75 | $0.89 | -$0.70 | $0.53 | |
| Diluted EPS (Cont. Ops) | $1.89 | $2.69 | $0.88 | -$0.70 | $0.52 | |
| Weighted Average Basic Share | $40.2M | $43.5M | $45.2M | $44.7M | $44.9M | |
| Weighted Average Diluted Share | $41.1M | $44.4M | $45.7M | $44.7M | $45.3M | |
| EBITDA | $161.4M | $246M | $190.6M | $99.2M | $189.8M | |
| EBIT | $116.6M | $178.5M | $122.2M | $37.5M | $113.7M | |
| Revenue (Reported) | $1.4B | $2.1B | $2.4B | $1.7B | $2.1B | |
| Operating Income (Reported) | $121.4M | $185.7M | $197.8M | $35.2M | $91.2M | |
| Operating Income (Adjusted) | $116.6M | $178.5M | $122.2M | $37.5M | $113.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $417.6M | $564.1M | $433.3M | $477.7M | $518.6M | |
| Revenue Growth (YoY) | 30.13% | 35.08% | -23.19% | 10.25% | 8.56% | |
| Cost of Revenues | $330.7M | $450.4M | $360.3M | $395.1M | $434.6M | |
| Gross Profit | $86.9M | $113.7M | $73M | $82.6M | $84M | |
| Gross Profit Margin | 20.81% | 20.16% | 16.85% | 17.29% | 16.2% | |
| R&D Expenses | $4.2M | $6.8M | $7.1M | $7M | $7.6M | |
| Selling, General & Admin | $42.3M | $61.2M | $53.5M | $58.3M | $63.5M | |
| Other Inc / (Exp) | -$4.3M | -- | $2.8M | -$3.8M | $800K | |
| Operating Expenses | $46.5M | $68M | $60.6M | $65.3M | $71.1M | |
| Operating Income | $40.4M | $45.7M | $12.4M | $17.3M | $12.9M | |
| Net Interest Expenses | $3.5M | $6.4M | $11.3M | $10.8M | $8.8M | |
| EBT. Incl. Unusual Items | $32.6M | $39.3M | $3.9M | $2.7M | $4.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7M | $8.5M | $3.5M | $9.9M | $7.4M | |
| Net Income to Company | $25.6M | $30.8M | $400K | -$7.2M | -$2.5M | |
| Minority Interest in Earnings | -$600K | -$2.9M | -$3.8M | -$2.2M | -$2.5M | |
| Net Income to Common Excl Extra Items | $25M | $27.9M | -$3.4M | -$9.4M | -$5M | |
| Basic EPS (Cont. Ops) | $0.62 | $0.62 | -$0.08 | -$0.21 | -$0.11 | |
| Diluted EPS (Cont. Ops) | $0.60 | $0.61 | -$0.08 | -$0.21 | -$0.11 | |
| Weighted Average Basic Share | $40.6M | $44.9M | $44.8M | $44.6M | $45.1M | |
| Weighted Average Diluted Share | $41.6M | $45.6M | $44.8M | $44.6M | $45.1M | |
| EBITDA | $47.6M | $63.6M | $30.4M | $34.1M | $33.8M | |
| EBIT | $36.2M | $45.7M | $15.7M | $14.9M | $14.8M | |
| Revenue (Reported) | $417.6M | $564.1M | $433.3M | $477.7M | $518.6M | |
| Operating Income (Reported) | $40.4M | $45.7M | $12.4M | $17.3M | $12.9M | |
| Operating Income (Adjusted) | $36.2M | $45.7M | $15.7M | $14.9M | $14.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $2.2B | $2.2B | $1.8B | $2.1B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.2B | $1.8B | $1.8B | $1.5B | $1.8B | |
| Gross Profit | $313M | $456.8M | $424.2M | $286.9M | $357.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $15.6M | $27.1M | $28.7M | $28.2M | $28.9M | |
| Selling, General & Admin | $158.2M | $238.7M | $231.1M | $218.6M | $241.9M | |
| Other Inc / (Exp) | -$7.3M | -$3.3M | -$73.6M | -$8.4M | $22.5M | |
| Operating Expenses | $173.8M | $265.8M | $259.8M | $246.8M | $270.8M | |
| Operating Income | $139.2M | $191M | $164.4M | $40.1M | $86.9M | |
| Net Interest Expenses | $14.6M | $26.7M | $38M | $44.2M | $39.8M | |
| EBT. Incl. Unusual Items | $117.3M | $161M | $52.8M | -$12.5M | $69.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $21.8M | $29.4M | $32.8M | $17.3M | $30.3M | |
| Net Income to Company | $95.5M | $131.6M | $20M | -$29.8M | $39.2M | |
| Minority Interest in Earnings | -$2.3M | -$9.2M | -$10.9M | -$7.3M | -$11.2M | |
| Net Income to Common Excl Extra Items | $93.2M | $122.4M | $9.1M | -$37.1M | $28.1M | |
| Basic EPS (Cont. Ops) | $2.31 | $2.73 | $0.18 | -$0.82 | $0.63 | |
| Diluted EPS (Cont. Ops) | $2.26 | $2.70 | $0.18 | -$0.82 | $0.62 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $177.5M | $262M | $157.3M | $102.9M | $189.8M | |
| EBIT | $132.6M | $188M | $92.1M | $36.7M | $113.9M | |
| Revenue (Reported) | $1.5B | $2.2B | $2.2B | $1.8B | $2.1B | |
| Operating Income (Reported) | $139.2M | $191M | $164.4M | $40.1M | $86.9M | |
| Operating Income (Adjusted) | $132.6M | $188M | $92.1M | $36.7M | $113.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $417.6M | $564.1M | $433.3M | $477.7M | $518.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $330.7M | $450.4M | $360.3M | $395.1M | $434.6M | |
| Gross Profit | $86.9M | $113.7M | $73M | $82.6M | $84M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $4.2M | $6.8M | $7.1M | $7M | $7.6M | |
| Selling, General & Admin | $42.3M | $61.2M | $53.5M | $58.3M | $63.5M | |
| Other Inc / (Exp) | -$4.3M | -- | $2.8M | -$3.8M | $800K | |
| Operating Expenses | $46.5M | $68M | $60.6M | $65.3M | $71.1M | |
| Operating Income | $40.4M | $45.7M | $12.4M | $17.3M | $12.9M | |
| Net Interest Expenses | $3.5M | $6.4M | $11.3M | $10.8M | $8.8M | |
| EBT. Incl. Unusual Items | $32.6M | $39.3M | $3.9M | $2.7M | $4.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7M | $8.5M | $3.5M | $9.9M | $7.4M | |
| Net Income to Company | $25.6M | $30.8M | $400K | -$7.2M | -$2.5M | |
| Minority Interest in Earnings | -$600K | -$2.9M | -$3.8M | -$2.2M | -$2.5M | |
| Net Income to Common Excl Extra Items | $25M | $27.9M | -$3.4M | -$9.4M | -$5M | |
| Basic EPS (Cont. Ops) | $0.62 | $0.62 | -$0.08 | -$0.21 | -$0.11 | |
| Diluted EPS (Cont. Ops) | $0.60 | $0.61 | -$0.08 | -$0.21 | -$0.11 | |
| Weighted Average Basic Share | $40.6M | $44.9M | $44.8M | $44.6M | $45.1M | |
| Weighted Average Diluted Share | $41.6M | $45.6M | $44.8M | $44.6M | $45.1M | |
| EBITDA | $47.6M | $63.6M | $30.4M | $34.1M | $33.8M | |
| EBIT | $36.2M | $45.7M | $15.7M | $14.9M | $14.8M | |
| Revenue (Reported) | $417.6M | $564.1M | $433.3M | $477.7M | $518.6M | |
| Operating Income (Reported) | $40.4M | $45.7M | $12.4M | $17.3M | $12.9M | |
| Operating Income (Adjusted) | $36.2M | $45.7M | $15.7M | $14.9M | $14.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $200.3M | $466.5M | $358.8M | $307M | $313.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $145.5M | $250.1M | $253.7M | $180.8M | $241.1M | |
| Inventory | $180.4M | $379.2M | $443.9M | $374.5M | $381M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $18.9M | $41.3M | $42.4M | $30.9M | $34.1M | |
| Total Current Assets | $545.1M | $1.1B | $1.1B | $893.2M | $970.1M | |
| Property Plant And Equipment | $197M | $325.7M | $378.6M | $480M | $486.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $171.1M | $270M | $248.8M | $265.2M | $265.3M | |
| Other Intangibles | $160.5M | $245.7M | $187.9M | $215.3M | $184.9M | |
| Other Long-Term Assets | $5.3M | $9.3M | $10.8M | $10.9M | $9.6M | |
| Total Assets | $1.1B | $2B | $2B | $1.9B | $1.9B | |
| Accounts Payable | $121.3M | $332.9M | $253.5M | $192.9M | $212.5M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $7.4M | $22.1M | $20.8M | $17.6M | $16M | |
| Current Portion Of Capital Lease Obligations | $11.7M | $17.3M | $17.1M | $18.1M | $18.6M | |
| Other Current Liabilities | $26.3M | $50M | $45.3M | $33.7M | $38.4M | |
| Total Current Liabilities | $201.2M | $469.1M | $389.2M | $310M | $335.6M | |
| Long-Term Debt | $261.6M | $529.9M | $493M | $461.2M | $476.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $551.3M | $1.1B | $1B | $970.5M | $984.1M | |
| Common Stock | $100K | $100K | $100K | $100K | $100K | |
| Other Common Equity Adj | $5.1M | -$200K | -$5.4M | -$4.4M | -$10.3M | |
| Common Equity | $532.6M | $848.9M | $887.9M | $838.9M | $873.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $18.6M | $43.8M | $49.1M | $58.3M | $62.2M | |
| Total Equity | $551.2M | $892.7M | $937M | $897.2M | $935.8M | |
| Total Liabilities and Equity | $1.1B | $2B | $2B | $1.9B | $1.9B | |
| Cash and Short Terms | $200.3M | $466.5M | $358.8M | $307M | $313.9M | |
| Total Debt | $269M | $552M | $513.8M | $478.8M | $492.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $264.3M | $367M | $322.1M | $293M | $317.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $168M | $279.3M | $190.3M | $194.5M | $217.9M | |
| Inventory | $189.2M | $440.3M | $433M | $388.1M | $374.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $14.7M | $36.1M | $35.8M | $33.1M | $37.7M | |
| Total Current Assets | $636.2M | $1.1B | $981.2M | $908.7M | $947.8M | |
| Property Plant And Equipment | $199M | $336.9M | $404.7M | $492.6M | $485.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $171.1M | $268.5M | $248.8M | $265.2M | $265.3M | |
| Other Intangibles | $155.6M | $237.6M | $182M | $207.6M | $177.6M | |
| Other Long-Term Assets | $6.4M | $9.3M | $12.6M | $10.2M | $11M | |
| Total Assets | $1.2B | $2B | $1.9B | $1.9B | $1.9B | |
| Accounts Payable | $164.9M | $288.1M | $196M | $215.7M | $207.4M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $8M | $19.5M | $22.7M | $17M | $10M | |
| Current Portion Of Capital Lease Obligations | $12.4M | $17.3M | $17.4M | $18.3M | $18.6M | |
| Other Current Liabilities | $46.9M | $51.9M | $39.8M | $41.3M | $37.5M | |
| Total Current Liabilities | $263.1M | $417.6M | $313.7M | $329.4M | $313.2M | |
| Long-Term Debt | $259.8M | $530.9M | $470M | $458.2M | $470.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $614M | $1.1B | $940.9M | $998.5M | $954.2M | |
| Common Stock | $100K | $100K | $100K | $100K | $100K | |
| Other Common Equity Adj | $1.6M | -$3M | -$8.5M | -$6.5M | -$9.8M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $19M | $46.7M | $54.3M | $58.2M | $64.8M | |
| Total Equity | $576.6M | $926.3M | $925M | $889.1M | $936.8M | |
| Total Liabilities and Equity | $1.2B | $2B | $1.9B | $1.9B | $1.9B | |
| Cash and Short Terms | $264.3M | $367M | $322.1M | $293M | $317.6M | |
| Total Debt | $267.8M | $550.4M | $492.7M | $475.2M | $480.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $80.4M | $126.4M | $50.4M | -$22.2M | $34.5M | |
| Depreciation & Amoritzation | $44.8M | $67.5M | $68.4M | $61.7M | $76.1M | |
| Stock-Based Compensation | $12.7M | $15.8M | $19.1M | $12.1M | $17.4M | |
| Change in Accounts Receivable | -$32.7M | -$53M | -$15.7M | $78.5M | -$60.3M | |
| Change in Inventories | -$8M | -$125.1M | -$84.4M | $80.8M | -$6.5M | |
| Cash From Operations | $97.3M | $211.6M | $47.2M | $135.9M | $65M | |
| Capital Expenditures | $36.4M | $59.3M | $100.1M | $75.8M | $63.5M | |
| Cash Acquisitions | -- | -$342.8M | $3.4M | -$46.1M | -- | |
| Cash From Investing | -$29.8M | -$404.8M | -$96.2M | -$119.7M | -$63.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -$300K | -$200K | -$500K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $76.7M | $415.2M | -- | -- | $67.7M | |
| Long-Term Debt Repaid | -$105.5M | -$131.8M | -$39.7M | -$38.6M | -$54.4M | |
| Repurchase of Common Stock | -- | -- | -$12.1M | -$29.4M | -- | |
| Other Financing Activities | -$2.9M | -$16.2M | -$4.6M | -$2.5M | -$5M | |
| Cash From Financing | -$31.1M | $460.8M | -$56M | -$69.9M | $9.8M | |
| Beginning Cash (CF) | $162.5M | $200.3M | $466.5M | $358.8M | $307M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $36.4M | $267.6M | -$105M | -$53.7M | $11.3M | |
| Ending Cash (CF) | $200.3M | $466.5M | $358.8M | $307M | $313.9M | |
| Levered Free Cash Flow | $60.9M | $152.3M | -$52.9M | $60.1M | $1.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $25.6M | $30.8M | $400K | -$7.2M | -$2.5M | |
| Depreciation & Amoritzation | $11.4M | $17.9M | $14.7M | $19.2M | $19M | |
| Stock-Based Compensation | $3.5M | $5.6M | $3.7M | $3.5M | $2.9M | |
| Change in Accounts Receivable | -$22.5M | -$29.1M | $63.4M | -$13.7M | $23.1M | |
| Change in Inventories | -$8.8M | -$61.1M | $10.9M | -$13.6M | $6.4M | |
| Cash From Operations | $65.6M | -$67.4M | $28M | $9.8M | $28.2M | |
| Capital Expenditures | $6.5M | $28.4M | $27.3M | $18M | $12.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $800K | -$28.4M | -$27.3M | -$17.9M | -$12.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $6.6M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$8.2M | -$2.6M | -$22M | -$4.5M | -$12M | |
| Repurchase of Common Stock | -- | -- | -$14.2M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$200K | |
| Cash From Financing | -$1.6M | -$2.6M | -$36.2M | -$4.5M | -$12.2M | |
| Beginning Cash (CF) | $200.3M | $466.5M | $358.8M | $307M | $313.9M | |
| Foreign Exchange Rate Adjustment | -$800K | -$1.1M | -$1.2M | -$1.4M | $100K | |
| Additions / Reductions | $64.8M | -$98.4M | -$35.5M | -$12.6M | $3.6M | |
| Ending Cash (CF) | $264.3M | $367M | $322.1M | $293M | $317.6M | |
| Levered Free Cash Flow | $59.1M | -$95.8M | $700K | -$8.2M | $15.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $95.5M | $131.6M | $20M | -$29.8M | $39.2M | |
| Depreciation & Amoritzation | $44.9M | $74M | $65.2M | $66.2M | $75.9M | |
| Stock-Based Compensation | $13.1M | $17.9M | $17.2M | $11.9M | $16.8M | |
| Change in Accounts Receivable | -$54.5M | -$59.6M | $76.8M | $1.4M | -$23.5M | |
| Change in Inventories | -$2.1M | -$177.4M | -$12.4M | $56.3M | $13.5M | |
| Cash From Operations | $147.2M | $78.6M | $142.6M | $117.7M | $83.4M | |
| Capital Expenditures | $36.2M | $81.2M | $99M | $66.5M | $57.9M | |
| Cash Acquisitions | -- | -$342.8M | $3.4M | -- | -- | |
| Cash From Investing | -$22.3M | -$434M | -$95.1M | -$110.3M | -$58M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$200K | -$500K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $31.8M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$99.2M | -$126.2M | -$59.1M | -$21.1M | -$61.9M | |
| Repurchase of Common Stock | -- | -- | -$26.3M | -$15.2M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$5.2M | |
| Cash From Financing | -$69.7M | $459.8M | -$89.6M | -$38.2M | $2.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $55.2M | $104.4M | -$42.1M | -$30.8M | $27.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $111M | -$2.6M | $43.6M | $51.2M | $25.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $25.6M | $30.8M | $400K | -$7.2M | -$2.5M | |
| Depreciation & Amoritzation | $11.4M | $17.9M | $14.7M | $19.2M | $19M | |
| Stock-Based Compensation | $3.5M | $5.6M | $3.7M | $3.5M | $2.9M | |
| Change in Accounts Receivable | -$22.5M | -$29.1M | $63.4M | -$13.7M | $23.1M | |
| Change in Inventories | -$8.8M | -$61.1M | $10.9M | -$13.6M | $6.4M | |
| Cash From Operations | $65.6M | -$67.4M | $28M | $9.8M | $28.2M | |
| Capital Expenditures | $6.5M | $28.4M | $27.3M | $18M | $12.4M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $800K | -$28.4M | -$27.3M | -$17.9M | -$12.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $6.6M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$8.2M | -$2.6M | -$22M | -$4.5M | -$12M | |
| Repurchase of Common Stock | -- | -- | -$14.2M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -$200K | |
| Cash From Financing | -$1.6M | -$2.6M | -$36.2M | -$4.5M | -$12.2M | |
| Beginning Cash (CF) | $200.3M | $466.5M | $358.8M | $307M | $313.9M | |
| Foreign Exchange Rate Adjustment | -$800K | -$1.1M | -$1.2M | -$1.4M | $100K | |
| Additions / Reductions | $64.8M | -$98.4M | -$35.5M | -$12.6M | $3.6M | |
| Ending Cash (CF) | $264.3M | $367M | $322.1M | $293M | $317.6M | |
| Levered Free Cash Flow | $59.1M | -$95.8M | $700K | -$8.2M | $15.8M | |
Get UCTT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
UCTT
Sector
P/E ratio
40.79x
23.84x
PEG ratio
0.00x
0.00x
P/B ratio
1.31x
2.31x
Price / LTM sales
0.53x
1.64x
Growth Metrics
UCTT
Sector
Revenue growth
8.56%
3.84%
Earnings growth
--
10.8%
Revenue (5-year growth)
14.49%
6.27%
Earnings forecast
$0.27
$0.12
Profitability
UCTT
Sector
Profitability FY 2024
$356.3M
$77.3M
Return on invested capital
2%
0.05%
Return on assets
1.47%
-0.48%
Return on equity
3.06%
0.73%
Earnings Date
Last Earnings Date
Apr
28
Next Earnings Date
Jul
28
Estimated Next Earnings Date
Jul
28
Balance Sheet
UCTT
Sector
Total cash
$317.6M
$48.7M
Short term investments
--
$19.4M
Total assets
$1.9B
$223.8M
Long term debt
$480.9M
$6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
